+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coagulants Market Size, Share & Trends Analysis Report By Product (Systemic, Topical, Hemostatics), By Application (Surgeries, Trauma, Hemophilia, Bleeding), By Route Of Administration, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990562
Description Jump to:
The global coagulants market size was estimated at USD 10.47 billion in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2030. The market in healthcare is primarily driven by the increasing prevalence of bleeding disorders and chronic diseases that require blood clotting factors for treatment. Conditions like hemophilia, von Willebrand disease, and thrombophilia necessitate the use of coagulants to manage and control them effectively. The rising incidence of these disorders globally is propelling the demand for this market.

Moreover, technological advancements and the development of novel coagulation therapies are driving innovation and expanding the sector. Manufacturers are investing in research and development to introduce more efficacious and safer products, including recombinant clotting factors and extended half-life products. These advancements aim to enhance patient outcomes, reduce treatment burden, and improve overall quality of life for individuals with bleeding disorders. According to Centers for Disease Control and Prevention, it's estimated that around 33,000 males in the U.S. are living with hemophilia as of May 2024.

Moreover, advancements in medical technology and research have led to development of novel coagulant products with improved efficacy and safety profiles. Innovations like recombinant clotting factors and extended half-life products offer patients more convenient treatment options and better outcomes. These technological advancements drive growth by expanding the range of available therapies and enhancing patient adherence to treatment regimens. In April 2024, Avenacy launched its FDA-approved Desmopressin Acetate Injection in the U.S., serving as a generic alternative to DDAVP Injection. This medication is aimed at treating central diabetes insipidus, hemophilia A, and Type I von Willebrand's disease.

Furthermore, favorable government initiatives and policies aimed at improving healthcare infrastructure and promoting preventive care are boosting the industry. Governments worldwide are focusing on enhancing access to quality healthcare services, including diagnostic testing facilities for early detection and management of disorders such as clotting factor deficiencies and hypercoagulable states. Incentives for research and development activities focused on hemostasis and thrombosis have also encouraged industry players to invest in developing cutting-edge technologies. For instance, initiatives like the National Hemophilia Program are done in collaboration with Centers for Disease Control and Prevention in the U.S. support research efforts to advance hemostasis-related treatments.

Regulatory requirements play a significant role in driving the healthcare industry. With the increasing emphasis on patient safety and quality care, several regulatory bodies including Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have implemented strict guidelines in healthcare settings. These regulations ensure that the products are safe, effective, and of high quality, thereby driving demand for these products. For instance, the FDA has established the Current Good Manufacturing Practice (CGMP) regulations to ensure that they are product under controlled conditions to maintain their identity, strength, quality, and purity. Compliance with these regulations requires manufacturers to invest in advanced technologies and equipment, which in turn drives the demand.

Global Coagulants Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the publisher has segmented the global coagulants market report based on product, application, route of administration, and region.
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Topical Coagulants
  • Absorbable Gelatin
  • Oxidized Cellulose
  • Microfibrillar Collagen
  • Other topical coagulants
  • Systemic Coagulants
  • Vitamin K
  • Protamine
  • Desmopressin
  • Fibrinogen
  • Other systemic coagulants
  • Hemostatics
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Surgeries
  • Trauma Cases
  • Hemophilia
  • Bleeding Disorders
  • Other Applications
  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Topical Administration
  • Parenteral Administration
  • Oral Administration
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Route of Administration
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and Application outlook
2.2.2. Route of Administration outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Coagulants Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements in diagnostic tools and treatment options
3.2.1.2. Increasing prevalence of coagulants disorders and chronic diseases
3.2.1.3. Expanding applications of coagulants testing in various medical fields including hematology, oncology, and critical care
3.2.2. Market restraint analysis
3.2.2.1. Regulatory Challenges
3.3. Coagulants Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
Chapter 4. Coagulants Market: Product Estimates & Trend Analysis
4.1. Global Coagulants Market: Product Dashboard
4.2. Global Coagulants Market: Product Movement Analysis
4.3. Global Coagulants Market by Product, Revenue
4.4. Topical Coagulants
4.4.1. Topical coagulants market estimates and forecasts 2018 to 2030, (USD Million)
4.4.2. Absorbable Gelatin
4.4.2.1. Absorbable gelatin market estimates and forecasts 2018 to 2030, (USD Million)
4.4.3. Oxidized Cellulose
4.4.3.1. Oxidized cellulose market estimates and forecasts 2018 to 2030, (USD Million)
4.4.4. Microfibrillar Collagen
4.4.4.1. Microfibrillar collagen market estimates and forecasts 2018 to 2030, (USD Million)
4.4.5. Other topical coagulants
4.4.5.1. Other topical coagulants market estimates and forecasts 2018 to 2030, (USD Million)
4.5. Systemic Coagulants
4.5.1. Systemic coagulants market estimates and forecasts 2018 to 2030, (USD Million)
4.5.2. Vitamin K
4.5.2.1. Vitamin K market estimates and forecasts 2018 to 2030, (USD Million)
4.5.3. Protamine
4.5.3.1. Protamine market estimates and forecasts 2018 to 2030, (USD Million)
4.5.4. Desmopressin
4.5.4.1. Desmopressin market estimates and forecasts 2018 to 2030, (USD Million)
4.5.5. Fibrinogen
4.5.5.1. Fibrinogen market estimates and forecasts 2018 to 2030, (USD Million)
4.5.6. Other systemic coagulants
4.5.6.1. Other systemic coagulants market estimates and forecasts 2018 to 2030, (USD Million)
4.6. Hemostatics
4.6.1. Hemostatics coagulants market estimates and forecasts 2018 to 2030, (USD Million)
Chapter 5. Coagulants Market: Application Estimates & Trend Analysis
5.1. Global Coagulants Market: Application Dashboard
5.2. Global Coagulants Market: Application Movement Analysis
5.3. Global Coagulants Market Estimates and Forecasts, By Application, Revenue (USD Million)
5.4. Surgeries
5.4.1. Surgeries market estimates and forecasts 2018 to 2030, (USD Million)
5.5. Trauma Cases
5.5.1. Trauma cases market estimates and forecasts 2018 to 2030, (USD Million)
5.6. Hemophilia
5.6.1. Hemophilia market estimates and forecasts 2018 to 2030, (USD Million)
5.7. Bleeding Disorders
5.7.1. Bleeding disorders market estimates and forecasts 2018 to 2030, (USD Million)
5.8. Other Applications
5.8.1. Other applications market estimates and forecasts 2018 to 2030, (USD Million)
Chapter 6. Coagulants Market: Route of Administration Estimates & Trend Analysis
6.1. Global Coagulants Market: Route of Administration Dashboard
6.2. Global Coagulants Market: Route of Administration Movement Analysis
6.3. Global Coagulants Market Estimates and Forecasts, by Route of Administration, Revenue (USD Million)
6.4. Topical Administration
6.4.1. Topical administration market estimates and forecasts 2018 to 2030, (USD Million)
6.5. Parenteral Administration
6.5.1. Parenteral administration market estimates and forecasts 2018 to 2030, (USD Million)
6.6. Oral Administration
6.6.1. Oral Administration market estimates and forecasts 2018 to 2030, (USD Million)
Chapter 7. Coagulants Market: Regional Estimates & Trend Analysis by Product, Application, and Route of Administration
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030, (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030, (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030, (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Vendor Landscape
8.2.1. List of key distributors and channel partners
8.2.2. Key customers
8.2.3. Key company market share analysis, 2023
8.2.4. Johnson & Johnson.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Baxter International Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Pfizer Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Bristol-Myers Squibb Company
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Sanofi S.A.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Bayer AG
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Novo Nordisk A/S.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. CSL Behring
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Octapharma AG
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Grifols S.A.
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
8.2.14. Amgen Inc.
8.2.14.1. Company overview
8.2.14.2. Financial performance
8.2.14.3. Product benchmarking
8.2.14.4. Strategic initiatives
8.2.15. Takeda Pharmaceutical Company Limited
8.2.15.1. Company overview
8.2.15.2. Financial performance
8.2.15.3. Product benchmarking
8.2.15.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America coagulants market, by region, 2018 - 2030 (USD Million)
Table 3 North America coagulants market, by product, 2018 - 2030 (USD Million)
Table 4 North America coagulants market, by application, 2018 - 2030 (USD Million)
Table 5 North America coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 6 U.S. coagulants market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. coagulants market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 9 Canada coagulants market, by product, 2018 - 2030 (USD Million)
Table 10 Canada coagulants market, by application, 2018 - 2030 (USD Million)
Table 11 Canada coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 12 Mexico coagulants market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico coagulants market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 15 Europe coagulants market, by region, 2018 - 2030 (USD Million)
Table 16 Europe coagulants market, by product, 2018 - 2030 (USD Million)
Table 17 Europe coagulants market, by application, 2018 - 2030 (USD Million)
Table 18 Europe coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 19 Germany coagulants market, by product, 2018 - 2030 (USD Million)
Table 20 Germany coagulants market, by application, 2018 - 2030 (USD Million)
Table 21 Germany coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 22 Germany coagulants market, by distribution channel, 2018 - 2030 (USD Million)
Table 23 UK coagulants market, by product, 2018 - 2030 (USD Million)
Table 24 UK coagulants market, by application, 2018 - 2030 (USD Million)
Table 25 UK coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 26 France coagulants market, by product, 2018 - 2030 (USD Million)
Table 27 France coagulants market, by application, 2018 - 2030 (USD Million)
Table 28 France coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 29 Italy coagulants market, by product, 2018 - 2030 (USD Million)
Table 30 Italy coagulants market, by application, 2018 - 2030 (USD Million)
Table 31 Italy coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 32 Spain coagulants market, by product, 2018 - 2030 (USD Million)
Table 33 Spain coagulants market, by application, 2018 - 2030 (USD Million)
Table 34 Spain coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 35 Denmark coagulants market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark coagulants market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 38 Sweden coagulants market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden coagulants market, by application, 2018 - 2030 (USD Million)
Table 40 Sweden coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 41 Norway coagulants market, by product, 2018 - 2030 (USD Million)
Table 42 Norway coagulants market, by application, 2018 - 2030 (USD Million)
Table 43 Norway coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 44 Asia Pacific coagulants market, by region, 2018 - 2030 (USD Million)
Table 45 Asia Pacific coagulants market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific coagulants market, by application, 2018 - 2030 (USD Million)
Table 47 Aisa Pacific coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 48 China coagulants market, by product, 2018 - 2030 (USD Million)
Table 49 China coagulants market, by application, 2018 - 2030 (USD Million)
Table 50 China coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 51 Japan coagulants market, by product, 2018 - 2030 (USD Million)
Table 52 Japan coagulants market, by application, 2018 - 2030 (USD Million)
Table 53 Japan coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 54 India coagulants market, by product, 2018 - 2030 (USD Million)
Table 55 India coagulants market, by application, 2018 - 2030 (USD Million)
Table 56 India coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 57 South Korea coagulants market, by product, 2018 - 2030 (USD Million)
Table 58 South Korea coagulants market, by application, 2018 - 2030 (USD Million)
Table 59 South Korea coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 60 Australia coagulants market, by product, 2018 - 2030 (USD Million)
Table 61 Australia coagulants market, by application, 2018 - 2030 (USD Million)
Table 62 Australia coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 63 Thailand coagulants market, by product, 2018 - 2030 (USD Million)
Table 64 Thailand coagulants market, by application, 2018 - 2030 (USD Million)
Table 65 Thailand coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 66 Latin America coagulants market, by region, 2018 - 2030 (USD Million)
Table 67 Latin America coagulants market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America coagulants market, by application, 2018 - 2030 (USD Million)
Table 69 Latin America coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 70 Brazil coagulants market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil coagulants market, by application, 2018 - 2030 (USD Million)
Table 72 Brazil coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 73 Argentina coagulants market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina coagulants market, by application, 2018 - 2030 (USD Million)
Table 75 Argentina coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 76 MEA coagulants market, by region, 2018 - 2030 (USD Million)
Table 77 MEA coagulants market, by product, 2018 - 2030 (USD Million)
Table 78 MEA coagulants market, by application, 2018 - 2030 (USD Million)
Table 79 MEA coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 80 South Africa coagulants market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa coagulants market, by application, 2018 - 2030 (USD Million)
Table 82 South Africa coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia coagulants market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia coagulants market, by application, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 86 UAE coagulants market, by product, 2018 - 2030 (USD Million)
Table 87 UAE coagulants market, by application, 2018 - 2030 (USD Million)
Table 88 UAE coagulants market, by route of administration, 2018 - 2030 (USD Million)
Table 89 Kuwait coagulants market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait coagulants market, by application, 2018 - 2030 (USD Million)
Table 91 Kuwait coagulants market, by route of administration, 2018 - 2030 (USD Million)
List of Figures
Fig.1 Market research process
Fig.2 Data triangulation techniques
Fig.3 Primary research pattern
Fig.4 Primary interviews in North America
Fig.5 Primary interviews in Europe
Fig.6 Primary interviews in APAC
Fig.7 Primary interviews in Latin America
Fig.8 Primary interviews in MEA
Fig.9 Market research approaches
Fig.10 Value-chain-based sizing & forecasting
Fig.11 QFD modeling for market share assessment
Fig.12 Market formulation & validation
Fig.13 Coagulants market: market outlook
Fig.14 Coagulants competitive insights
Fig.15 Parent market outlook
Fig.16 Related/ancillary market outlook
Fig.17 Coagulants market driver impact
Fig.18 Coagulants market restraint impact
Fig.19 Coagulants market: Product movement analysis
Fig.20 Coagulants market: Product outlook and key takeaways
Fig.21 Topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.22 Absorbable gelatin market estimates and forecast, 2018 - 2030 (USD Million)
Fig.23 Oxidized cellulose market estimates and forecast, 2018 - 2030 (USD Million)
Fig.24 Microfibrillar collagen market estimates and forecast, 2018 - 2030 (USD Million)
Fig.25 Other topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.26 Systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.27 Vitamin K market estimates and forecast, 2018 - 2030 (USD Million)
Fig.28 Protamine market estimates and forecast, 2018 - 2030 (USD Million)
Fig.29 Desmopressin market estimates and forecast, 2018 - 2030 (USD Million)
Fig.30 Fibrinogen market estimates and forecast, 2018 - 2030 (USD Million)
Fig.31 Other systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig.32 Hemostatics market estimates and forecast, 2018 - 2030 (USD Million)
Fig.33 Coagulants market: Application product movement analysis
Fig.34 Coagulants market: Application product outlook and key takeaways
Fig.35 Surgeries market estimates and forecast, 2018 - 2030 (USD Million)
Fig.36 Trauma Cases market estimates and forecast, 2018 - 2030 (USD Million)
Fig.37 Hemophilia market estimates and forecast, 2018 - 2030 (USD Million)
Fig.38 Bleeding Disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig.39 Other Applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig.40 Coagulants market: Route of administration movement analysis
Fig.41 Coagulants market: Route of administration outlook and key takeaways
Fig.42 Topical Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.43 Parenteral Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.44 Oral Administration market estimates and forecast, 2018 - 2030 (USD Million)
Fig.45 Global Coagulants market: Regional outlook and key takeaways
Fig.46 Global Coagulants market share and leading players
Fig.47 North America, by country
Fig.48 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.49 U.S. key country dynamics
Fig.50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.51 Canada key country dynamics
Fig.52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.53 Mexico key country dynamics
Fig.54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.56 UK key country dynamics
Fig.57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.58 Germany key country dynamics
Fig.59 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.60 France key country dynamics
Fig.61 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.62 Italy key country dynamics
Fig.63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.64 Spain key country dynamics
Fig.65 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.66 Denmark key country dynamics
Fig.67 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.68 Sweden key country dynamics
Fig.69 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.70 Norway key country dynamics
Fig.71 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.72 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.73 China key country dynamics
Fig.74 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.75 Japan key country dynamics
Fig.76 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.77 India key country dynamics
Fig.78 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.79 Thailand key country dynamics
Fig.80 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.81 South Korea key country dynamics
Fig.82 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.83 Australia key country dynamics
Fig.84 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.85 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.86 Brazil key country dynamics
Fig.87 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.88 Argentina key country dynamics
Fig.89 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.91 South Africa key country dynamics
Fig.92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.93 Saudi Arabia key country dynamics
Fig.94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.95 UAE key country dynamics
Fig.96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.97 Kuwait key country dynamics
Fig.98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig.99 Market share of key market players- coagulants market

Companies Mentioned

  • Johnson & Johnson.
  • Baxter International Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Sanofi S.A.
  • Bayer AG
  • Novo Nordisk A/S.
  • CSL Behring
  • Octapharma AG
  • Grifols S.A.
  • Amgen Inc.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 10.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.01 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Inorganic Coagulant Market by Type, Form, Grade, Application, End-Use Industries - Global Forecast 2025-2030 - Product Image

Inorganic Coagulant Market by Type, Form, Grade, Application, End-Use Industries - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Microbial Coagulants Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031 - Product Image

Microbial Coagulants Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031

  • Report
  • 144 Pages
  • Global
From
Coagulants Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, and Product Type - Product Image

Coagulants Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, and Product Type

  • Report
  • 112 Pages
  • Global
From
Iron Based Coagulant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Iron Based Coagulant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
Hypofibrinogenemia - Pipeline Insight, 2024 - Product Image

Hypofibrinogenemia - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From

About the Coagulant Market

Coagulants are a type of hematological drug used to treat and prevent excessive bleeding. They work by helping the body form clots to stop bleeding. Coagulants are used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. They are also used to prevent excessive bleeding during surgery and childbirth. Coagulants are available in both oral and injectable forms. The coagulant market is a rapidly growing segment of the hematological drug market. It is driven by the increasing prevalence of bleeding disorders, the growing demand for safer and more effective treatments, and the development of new drugs. The market is expected to continue to grow in the coming years, driven by the increasing demand for coagulants and the development of new drugs. Some of the major companies in the coagulant market include Bayer AG, Pfizer Inc., Novo Nordisk A/S, Sanofi S.A., and CSL Behring. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.